Preclinical Toxicology Services
Comprehensive Preclinical Toxicology Services Across the U.S.
Lovelace Biomedical is a nationally recognized leader in preclinical toxicology services, offering unmatched scientific depth, regulatory insight, and operational excellence. Based in Albuquerque, New Mexico, and serving clients nationwide, we provide end-to-end study design, execution, and analysis for small molecules, biologics, and advanced therapy programs. Our preclinical toxicology services are designed to accelerate discovery, reduce risk, and ensure compliance with FDA and global regulatory standards.
Unmatched Experience in Preclinical Toxicology Services
With over 70 years of toxicology experience, Lovelace Biomedical has built a reputation for excellence in preclinical toxicology services that support every phase of drug development. Our team includes more than 50 cross-trained research technicians and experienced study directors, over half of whom hold Ph.D. degrees. Together, we execute complex preclinical toxicology services with precision, transparency, and scientific rigor. Each study is tailored to meet specific sponsor requirements, ensuring high-quality data and regulatory confidence.
Comprehensive Capabilities for Every Therapeutic Modality
Our 300,000 square feet of advanced laboratory space is equipped for a wide range of preclinical toxicology services, including inhalation, genetic, and toxicokinetic studies. We specialize in both GLP and non-GLP programs, supporting diverse therapeutic modalities such as small molecules, biologics, gene therapies, and cell therapies. Lovelace Biomedical’s preclinical toxicology services also encompass dosimetric evaluations, tissue-specific compound analysis, and physiological assessments that inform IND-enabling decisions.
Trusted Partner for Regulatory-Ready Preclinical Toxicology Services
Our preclinical toxicology services are conducted under strict compliance with FDA, EPA, and OECD guidelines. Lovelace Biomedical supports successful IND, NDA, and BLA submissions with well-documented study reports that meet global expectations. Our scientists work closely with sponsors to align preclinical toxicology services with evolving regulatory requirements, enabling informed decision-making and accelerated timelines. Whether you’re developing a new oncology therapy or advancing an innovative biologic, our preclinical toxicology services provide the insight needed to move forward confidently.
Collaborative Approach to Preclinical Toxicology Service
At Lovelace Biomedical, collaboration is the foundation of our preclinical toxicology services. From study design to final reporting, we keep communication transparent and responsive. Our cross-functional teams integrate toxicology, pharmacology, and pathology expertise to streamline your program. Through our preclinical toxicology services, you gain a trusted partner dedicated to your success and committed to delivering scientifically sound, actionable data.
Contact Our Business Development Office to Learn More
Lovelace Biomedical’s preclinical toxicology services combine decades of experience, cutting-edge technology, and regulatory expertise to help you advance your program with confidence. Based in Albuquerque and serving clients across the U.S., we’re ready to support your next study with precision and scientific excellence. Contact our Business Development Office today to discuss your preclinical toxicology services needs and discover how Lovelace Biomedical can accelerate your path to clinical success.